This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rissing, J. P.
Right arrow Articles by Moore, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rissing, J. P.
Right arrow Articles by Moore, W. L., Jr.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1978 October; 14(4): 636-638
Copyright © 1978 American Society for Microbiology. All Rights Reserved.

Artifactual Depression of Serum Glutamic Oxaloacetic Transaminase by Metronidazole

J. Peter Rissing, Cheryl Newman and William L. Moore Jr.

Veterans Administration Hospital and Department of Medicine, Medical College of Georgia, Augusta, Georgia 30904

ABSTRACT

Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole therapy. Metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.


Antimicrob Agents Chemother. 1978 October; 14(4): 636-638
Copyright © 1978 American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Lambert, J. R., Thomas, S. M. (1985). Metronidazole Prevention of Serum Liver Enzyme Abnormalities during Total Parenteral Nutrition. JPEN J Parenter Enteral Nutr 9: 501-503 [Abstract]